The use of immunotherapy in older patients with advanced non-small cell lung cancer

Lung cancer is one of the most frequently occurring cancer worldwide and is responsible for the greatest burden in terms of cancer-related deaths [1]. Based on the Surveillance, Epidemiology, and End Results (SEER) database, it has been estimated that 47% of lung cancer diagnoses performed before 2003 in the U.S. occurred in patients aged 70 or above, with 14% of the cases diagnosed in patients aged 80 years and older (i.e., “oldest old” patients) [2], while as of 2018 more than 35% of new lung cancer cases were done in subjects aged more than 75 [3].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Source Type: research